AuNPs were synthesized by the citrate reduction method described by Turkevich and 
For the synthesis, 0.6 mmoles of a-Amine-ω-azido hepta(ethylene glycol) were added to 12.5 mL of dimethylsulfoxide under argon atmosphere in a poly(ethylene glycol) bath at 50ºC and under continuous stirring. Subsequently, 0.63 mmol of γ-tiobutirolactone and 5.7 mmol of triethylamine were added. After 5 hr, the mixture was cooled down and lyophilised obtaining a yellow oil. The yield of the reaction was 93%, without any further purification step. The product was characterised by: FT-IR: 3301 cm-1 (NH st), 2870 cm-1 (-CH st), 2530 cm-1 (SH st), 2106 cm-1 (N 3 st), 1663 cm-1 (C=O st); H-RMN 300 MHz (d): 2,00 (m, 2H); 2,25 (t, 2H, J=7,30 Hz); 2,65 (t, 1 Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2018 2H, J=7,00 Hz); 3,01 (s, 1H, SH); 3,32 (t, 4H, J = 5,00 Hz); 3,37 (t, 2H, J = 5,22 Hz); 3,59 (s, 22H); 6,60 (t, 1H, J = 4,76 Hz) and mass spectroscopy [M-H+] 451.1.
Functionalization of Au@Citr with thiolated polyethyleneglycol (PEG)
For Au@COOH to a 10 nM solution of Au@Citr, it was added SDS 0.028% (w/V), 52 µM of HS-EG(8)-(CH 2 ) 2 -COOH, followed by NaOH to a final concentration 25 mM. For N 3 @Au@COOH 25:75 sat the protocol followed was the same but it was added 13 µM of HS-(CH 2 ) 3 -CONH-EG(6)-(CH 2 ) 2 -N 3 (PEG-N 3 ) and 39 µM of PEG-COOH. In both cases the mixture was kept stirring at room temperature for 16 hours and washed by centrifugation 3 times at 14000 rpm for 30 minutes at 4˚C.
Functionalization with RGD and (2-aminoethyl)trimethylammonium chloride hydrochloride (R'R3N+)
The functionalization of Au@COOH and N 3 @Au@COOH was done following the same protocol.
In first place, (1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide) (EDC, 10.4 µmol) and sulfo-NHS (18 µmol) were mixed in buffer MES 0.1M pH 6 and stirred for 10 minutes, followed by the addition of 20 pmol of the AuNPs and MiliQ water to a final volume of 1 mL. The mixture was incubated for 20 minute and the excess of reactants was eliminated by centrifugation with Amicon-Ultra® de 100KDa. Finally, the AuNPs were resuspended in 1 mL of MES 50 mM pH 6 and it was added 22.8 mM of R'R 3 N + and/or 4 µM of G-RGD-S. It was incubated for 2 hours at room temperature before proceeding to centrifuge the samples 3 times at 14000 rpm for 30 minutes at 4ºC in order to remove the excess of reactants.
Quantification of PEG-chains attached
It has been described elsewhere. 41 In brief, the excess of PEG-COOH was determined by Ellman's assay, following the protocol for the determination of free thiol groups. In the case of PEG-N 3 , as this compound is frequently found as a disulfide, it was determined in an indirect way analyzing the decrease in the ability of attaching PEG-COOH as the concentration of PEG-N 3 increased, quantified again by Ellman's assay. The AuNPs were also characterized by FT-IR ( Figure S1 ).
Determination of quaternary ammonium attached
The effective functionalization of the AuNPs with R'R 3 N + was determined by the change in the net charge of the nanoparticles once functionalized. The analysis was made by electrophoresis in agarose gels ( Figure S2A ) and ζ potential ( Figure S2B ) in comparison with the AuNPs without fuctionalization. Agarose gel electrophoresis was carried out with 1% (w/V) agarose gels prepared in 0.5X Tris-Borate-EDTA buffer (TBE). The samples were loaded by mixing 8 µL of AuNPs in water with 2 µL of glycerol:TBE (1:4) and allowed to run for 30 minutes at 80V. ζ potential measurements were taken in a Brookhaven Zeta PALS. The samples were diluted to 1.6 mL with KCl 1 mM to a final concentration 2 nM and the pH was afterwards adjusted at 7.4 with NaOH 2M and HCl 1M.
Determination of RGD attached
The peptide RGD bound to the AuNPs was determined in an indirect way by quantification of a fluorophore attached when added in a competing way. To this aim, the functionalization was made following the same protocol described before but adding tetramethylrhodamine 5-(and 6-) carboxamide cadaverine (TAMRA) at a final concentration 20 µM. After removing the excess of reactants by centrifugation, the supernatants were kept and the intensity of fluorescence was measured (excitation filter 560±40 and emission filter 620±40). Analyzing the difference with and without the RGD it was possible to confirm the presence of the peptide on the AuNPs ( Figure S3 ).
Characterization of MSCs and analysis of viral infection with commercial agents.
Mesenchymal stem cells were infected with Ad-CMV-GFP at the experimental moi, alone or mixed with jetPEI-RGD or without virus (as infection controls or for the analyses of MSCs surface markers expression), were plated at a density of 10 5 onto 6 well plates following the protocol previously described. 48 hours after infection (or after seeding for uninfected cells) were washed with PBS, and harvested to check surface markers. CD105, Sca-1 and CD73 were used to positively identify bone marrow MSCs and surface markers CD45 and CD31 were used as negative controls ( Figure S4 . The antibodies used were a rat anti-mouse (Ly-6a/E) monoclonal antibody for Sca-1, a rat anti-mouse (TY/23) monoclonal antibody for CD73, a mouse anti-mouse (Ly-5.2) monoclonal antibody for CD45, and a rat-antimouse (PECAM-1) monoclonal antibody for CD31 (all from BD Pharmigen), and a rat anti-mouse monoclonal antibody for CD105 (MJ17/8) (Santa Cruz Biotechnoly Inc). In addition, a mouse anti-CAR antibody (H-300) from Millipore was used to check CAR levels on the MSCs. Antibodies were PE or Biotin conjugated and were prepared at working solutions of 0.1 µg/µL. Cells were divided in groups of 105cells/tube including isotype tubes as controls. Cells were washed in PBS, were incubated with the primary antibody for 20 minutes on ice. Following incubation, the primary antibody was washed from the cells by centrifugation x3 in PBS and the secondary-FITC antibody (Molecular Probes) was added and incubated for 20 minutes on ice and shielded from light. After 20 minutes, the secondary antibody was washed, cells were resuspended in 300 µL of PBS and analysed by flow cytometry (FACSAria, BD).
Optimization of commercial transfection agents for viral transfection of MSCs with Ad-CMV-

GFP
Protocols were adapted from the use of pDNA. Twenty-four hours prior to the transduction, bone marrow-derived MSCs were seeded at a density of 1 x 10 5 cells per well in 6 well plates.
Complexes used for transfection were Lipofectamine2000 transfection reagent (ThemoFisher) and two polyethylenimine derivatives, jetPEI and jetPEI-RGD (Polyplus transfection). Complexes of Ad-CMV-GFP with jetPEI and jetPEI-RGD ) were prepared as follows: 1) 0.3-6µL Jet PEI or Jet PEI-RGD were diluted in 150 mM NaCl to a final volume of 100 µL. 2) The viral amount corresponding to 50-1000 moi was diluted in 150 mM NaCl to a final volume of 100 µL. The full volume of 100 µL jetPEI solution was added to the 100 µl viral solution (but not in reverse order) and incubated for 30 minutes at room temperature. For Lipofectamine (ThermoFisher), complexes were formed in cell culture media without serum using 5-12.5 µL. After the complexion, the solutions were added drop-wise into the medium of the cultured cells and incubated at 37ºC, 5% CO 2 and 3% O 2 .
Immunocytochemistry
After the fixation, samples were washed with PBS and permeabilized with PBS-0.1% Triton X-100 for 10 min prior to being incubated for 60 min in blocking buffer (PBS-BSA 1%). This was followed by the addition of anti-β-tubulin monoclonal primary antibody (1:100 in PBS/BSA, anti-mouse, Sigma) for 1h at 37°C. The samples were then washed in 0.5% Tween20/PBS and a secondary, biotinylated anti-mouse IgG (1:100 in PBS/BSA) was added for 45 min at room temperature followed by another washing step. Afterwards, it was added streptavidin-Texas Red at a concentration 10 µg/mL for 30 minutes at 4°C. Finally, after another washing step, coverslips were incubated with DAPI for 10 minutes at 4°C, washed with distilled water and mounted with Prolong Gold Antifade Reagent before viewed using a fluorescence microscope (Nikon eclipse Ti).
Western-Blot
In brief, cells were seeded and transduced as previously described, cells and supernatant were pelleted and 100 µL of lysis buffer (150 mm NaCl, 50mM Tris pH 7.5, 0.05% SDS, 1% Triton X-100) was added. The resulting homogenate was sonicated on ice, and the supernatant was used for the experiment. 20 µg of protein extract were separated on 10% SDS-polyacrylamide gels and transferred onto nitrocellulose filters by semidry blotting. Primary antibodies used were mouse monoclonal anti-GFP (N-ter) (Cancer Research-UK antibodies services), mouse anti-beta-tubulin (Sigma Aldrich), and a mouse anti-CAR antibody (H-300) (Millipore), and conditions were according to manufacturer instructions. Figure S1 . FT-IR spectra of Au@citr (black line) and N3@Au@COOH (grey line). 
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